Researchers applied exosome derived from human umbilical cord MSCs (hUCMSCs) and engineered them exogenously with a cyclic peptide, arginine-glycine-aspartate to encapsulate triptolide to establish a bionic-targeted drug delivery system, achieving synergism and toxicity reduction.
[Journal of Nanobiotechnology]